Health TrialsbyHealthPanel

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

ConditionsPancreas DiseaseLiver DiseasesSurgical Procedure, UnspecifiedBile Duct Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-90
SponsorFundacion Miguel Servet

About this trial

The main aims of this study are:

1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)

All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).

Disqualifiers

Patients not eligible for surgery

Patients not interested in taking part in the study

Trial population

All out-patients and in-patients at the HPB Surgical Unit

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Hepatobiliopancreatic surgery

    Procedure/Surgery

    Different surgical techniques tailored to each patient´s pathology

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Rate of patient with post-surgical morbidity and mortality operated by the HPB Surgical Unit

Morbidity and mortality outcomes are evaluated following the criteria and definitions from Claven-Dindo and ISGPS international classifications

Time frame
90 days post-surgery
2

Survival rate of patients operated by the HPB Surgical Unit

These patients are operated due to tumoral cause

Time frame
5-years post-surgery
3

Disease-free survival rate of patients operated by the HPB Surgical Unit

These patients are operated due to tumoral cause

Time frame
5-years post-surgery

Secondary outcomes

1

Assessment of standardization of pre and post-surgical care

Time frame
90 days
2

Evaluation of the result of the multimodal treatment

Time frame
90 days
3

Assessment of the oncological quality standards of patients operated by HPB Surgical Unit due to tumoral cause

Time frame
5 years
4

Assessment of the results from minimally invasive techniques in HPB surgery

Time frame
90 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fundacion Miguel Servet

Lead sponsor

Source ClinicalTrials.gov
Apply now